A randomised control trial comparing Ropivacaine, levobupivacaine and bupivacaine for spinal anaesthesia for caesarean section

A randomised control trial comparing intrathecal ropivacaine, levobupivacaine and bupivacaine for caesarean section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011711

Enrollment

100

Registered

2018-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Term Pregnant Patients with uncomplicated pregnancy scheduled to for Caesarean Section

Interventions

Intervention1: Isobaric levobupivacaine for spinal anaesthesia: In the test group 1, Isobaric levobupivacaine will be used for spinal anaesthesia Intervention2: Isobaric Ropivacaine for spinal ana

Eligibility

Inclusion criteria

Inclusion criteria: Full term patients scheduled for caesarean section of ASA status1 and 2, age group of 18 to 40 years, body weight of 45 to 85 kg and height of 145 to165cm.

Exclusion criteria

Exclusion criteria: Parturients with hypersensitivity to local anesthetics, contraindications to neuraxial block, twin pregnancy, obstetric complications or fetal compromise were excluded

Design outcomes

Primary

Measure	Time frame
Duration of motor blockTimepoint: Duration of motor block	—

Secondary

Measure	Time frame
Sensory and Motor block onset times Sensory and Motor block regression times First analgesic request time Hemodynamic Parameters Apgar Scores Quality of Anaesthesia and Muscle relaxation Side-EffectsTimepoint: Intra and Post operative Period	—

Countries

India

Contacts

Public ContactDivya Sethi

ESI-PGIMSR, New Delhi

divyasth@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026